Redefining hypoglycemia in clinical trials: validation of definitions recently adopted by the American Diabetes Association/European Association for the study of diabetes von Heller, S.R, Buse, J.B, Ratner, R, Seaquist, E, Bardtrum, L, Hansen, C.T, Tutkunkardas, D, Moses, A.C

Volltext bestellen

Short‐term cost‐utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9)... von Pollock, R.F, Heller, S, Pieber, T.R, Woo, V, Gundgaard, J, Hallén, N, Luckevich, M, Tutkunkardas, D, Zinman, B

Volltext bestellen